U.S. Markets closed

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
22.88+1.01 (+4.62%)
At close: 04:00PM EST
22.90 +0.02 (+0.09%)
After hours: 04:31PM EST

Collegium Pharmaceutical, Inc.

100 Technology Center Drive
Suite 300
Stoughton, MA 02072
United States
781 713 3699

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees152

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.Co-Founder & Chairman110kN/A1964
Mr. Joseph J. CiaffoniPres, CEO & Director1.1M945.21k1971
Ms. Colleen TupperExec. VP & CFO631.24kN/A1976
Ms. Shirley R. KuhlmannExec. VP, Gen. Counsel, Chief Admin. Officer & Sec.620.1kN/A1984
Mr. Scott DreyerExec. VP & Chief Commercial Officer591kN/A1973
Dr. Richard Malamut M.D.Exec. VP & Chief Medical Officer612.2kN/A1960
Ms. Alex DasallaHead of Investor RelationsN/AN/AN/A
Mr. Bart J. DunnExec. VP of Strategy & Corp. Devel.N/AN/AN/A
Ms. Marlo ManningHead of HRN/AN/AN/A
Mr. Scott SudduthHead of Technical OperationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Corporate Governance

Collegium Pharmaceutical, Inc.’s ISS Governance QualityScore as of October 1, 2022 is 2. The pillar scores are Audit: 9; Board: 3; Shareholder Rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.